SOT ToxExpo sits early in the development timeline. Much of the work there is preclinical safety ahead of an IND filing, which makes presence a leading indicator: an account active at SOT is often months ahead of the clinical-trial signal that follows, and worth engaging before that program becomes obvious to everyone else.
What SOT ToxExpo is
The SOT Annual Meeting & ToxExpo, run by the Society of Toxicology, is a leading US toxicology meeting. Much of the science presented is preclinical safety and toxicology assessment, a large share of it in the run-up to an IND filing. Its audience is weighted toward preclinical safety, toxicology, and drug-safety scientists at biotech and pharma, along with the CROs, specialty labs, and tools vendors that support preclinical safety and toxicology testing.
The GTM signal at SOT ToxExpo
Exhibiting at SOT reflects a budgeted decision to be visible to a preclinical safety audience, the same strongest-signal logic that applies at any show. The distinctive value here is timing: because toxicology work tends to precede an IND and the clinical program that follows, presence at SOT can flag a program approaching its first IND well before a clinical-trial registration makes it visible. A named presenter tied to a specific safety dataset is a sharp contact-level hook. See selling around life science conferences for how to weigh the signals.
The outreach window
Exhibitor and speaker lists become public ahead of the March meeting, giving a window to cross-reference the roster against your account list and plan specific outreach before the floor opens. Because the signal is early, the best use is often to open a relationship now and combine it with the clinical-trial signal that tends to follow months later, timing the substantive outreach to when the program moves toward the clinic. On-site outreach works as a fallback, and the post-show window holds for a few weeks while a reference to a specific conversation is still fresh.
Who this matters most for
A CRO offering preclinical safety, toxicology, or early-development services should treat SOT ToxExpo as a primary show and a leading indicator for accounts approaching an IND. A tools or services vendor serving preclinical safety and toxicology workflows will find a close-fit audience. A CDMO can use SOT to identify programs early and build the relationship ahead of a later manufacturing need.